secwatch.observer — SEC 8-K summary
======================================

Issuer:     Traws Pharma, Inc. (TRAW)
CIK:        0001130598
Form:       8-K
Filed at:   2026-07-09T20:01:22+00:00
Accession:  0001104659-26-082250
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Traws Pharma shareholders approve 2M share increase in incentive plan and warrant issuance at annual meeting
--------------------------------------------------------------------------------

- Stockholders approved amendment to 2021 Incentive Compensation Plan, increasing authorized shares by 2,000,000 (4,821,796 for, 1,694,075 against).
- Proposal 4 approved issuance of shares upon exercise of Series B and C Warrants issued under April 15, 2026 Securities Purchase Agreement (2,270,414 for, 151,196 against).
- All seven director nominees elected; KPMG ratified as auditor for FY 2026 (7,659,805 for).
- Certain shares (3,486,423) excluded from voting on Proposal 4 per Nasdaq rules; total outstanding shares 15,150,669 as of May 18, 2026 record date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1130598/000110465926082250/0001104659-26-082250-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1130598/000110465926082250/tm2620113d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-082250

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer